These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 32462520)
1. Comprehensive analysis of the expression and prognosis for TFAP2 in human lung carcinoma. Cheng C; Ai Z; Zhao L Genes Genomics; 2020 Jul; 42(7):779-789. PubMed ID: 32462520 [TBL] [Abstract][Full Text] [Related]
2. Comprehensive Analysis of Prognostic Value and Immune Infiltration of TFAP2 Family Members in Bladder Cancer from Database and FFPE Sample. Yuan F; Sun Y; Dai GC; Yao Q; Zhou YB; Zang YC; Liu XL; Xue BX J Cancer; 2023; 14(16):3050-3065. PubMed ID: 37859819 [No Abstract] [Full Text] [Related]
3. Analysis of the Expression of Chen C; Chen S; Pang L; Yan H; Luo M; Zhao Q; Lai J; Li H Biomed Res Int; 2020; 2020():6412593. PubMed ID: 32104702 [TBL] [Abstract][Full Text] [Related]
4. Mining expression and prognosis of topoisomerase isoforms in non-small-cell lung cancer by using Oncomine and Kaplan-Meier plotter. Hou GX; Liu P; Yang J; Wen S PLoS One; 2017; 12(3):e0174515. PubMed ID: 28355294 [TBL] [Abstract][Full Text] [Related]
5. Comprehensive genomic and prognostic analysis of the IL‑17 family genes in lung cancer. Liao T; Fan J; Lv Z; Xu J; Wu F; Yang G; Huang Q; Guo M; Hu G; Zhou M; Duan L; Wang S; Jin Y Mol Med Rep; 2019 Jun; 19(6):4906-4918. PubMed ID: 31059089 [TBL] [Abstract][Full Text] [Related]
6. Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C. Chang TH; Tsai MF; Gow CH; Wu SG; Liu YN; Chang YL; Yu SL; Tsai HC; Lin SW; Chen YW; Kuo PY; Yang PC; Shih JY Cancer Lett; 2017 Aug; 402():190-202. PubMed ID: 28610956 [TBL] [Abstract][Full Text] [Related]
7. Prognostic roles of mRNA expression of notch receptors in non-small cell lung cancer. Xiong J; Zhang X; Chen X; Wei Y; Lu DG; Han YW; Xu J; Yu D Oncotarget; 2017 Feb; 8(8):13157-13165. PubMed ID: 28061457 [TBL] [Abstract][Full Text] [Related]
8. Prognostic alternative mRNA splicing signature in non-small cell lung cancer. Li Y; Sun N; Lu Z; Sun S; Huang J; Chen Z; He J Cancer Lett; 2017 May; 393():40-51. PubMed ID: 28223168 [TBL] [Abstract][Full Text] [Related]
9. Loss of β-arrestin1 expression predicts unfavorable prognosis for non-small cell lung cancer patients. Ma H; Wang L; Zhang T; Shen H; Du J Tumour Biol; 2016 Jan; 37(1):1341-7. PubMed ID: 26293896 [TBL] [Abstract][Full Text] [Related]
10. Analyses of expressions and prognostic values of Polo-like kinases in non-small cell lung cancer. Zeng Y; Li N; Liu W; Zeng M; Cheng J; Huang J J Cancer Res Clin Oncol; 2020 Oct; 146(10):2447-2460. PubMed ID: 32627077 [TBL] [Abstract][Full Text] [Related]
11. Molecular Changes of Lung Malignancy in HIV Infection. Zheng J; Wang L; Cheng Z; Pei Z; Zhang Z; Li Z; Zhang X; Yan D; Xia Q; Feng Y; Song Y; Chen W; Zhang X; Xu J; Wang J Sci Rep; 2018 Sep; 8(1):13128. PubMed ID: 30177858 [TBL] [Abstract][Full Text] [Related]
12. Crucial role of the transcription factors family activator protein 2 in cancer: current clue and views. Jin C; Luo Y; Liang Z; Li X; Kołat D; Zhao L; Xiong W J Transl Med; 2023 Jun; 21(1):371. PubMed ID: 37291585 [TBL] [Abstract][Full Text] [Related]
13. Notch Signaling Components: Diverging Prognostic Indicators in Lung Adenocarcinoma. Liu ZY; Wu T; Li Q; Wang MC; Jing L; Ruan ZP; Yao Y; Nan KJ; Guo H Medicine (Baltimore); 2016 May; 95(20):e3715. PubMed ID: 27196489 [TBL] [Abstract][Full Text] [Related]
14. Identification of 17 mRNAs and a miRNA as an integrated prognostic signature for lung squamous cell carcinoma. Zhang J; Bing Z; Yan P; Tian J; Shi X; Wang Y; Yang K J Gene Med; 2019 Aug; 21(8):e3105. PubMed ID: 31215090 [TBL] [Abstract][Full Text] [Related]
15. [Significance of immunohistochemical indicators in diagnosis and prognosis of squamous cell carcinoma and adenocarcinoma of lung]. Ma Y; Fan M; Chen K Zhongguo Fei Ai Za Zhi; 2014 Jun; 17(6):506-10. PubMed ID: 24949694 [No Abstract] [Full Text] [Related]
16. RBX1 expression is an unfavorable prognostic factor in patients with non-small cell lung cancer. Xing R; Chen KB; Xuan Y; Feng C; Xue M; Zeng YC Surg Oncol; 2016 Sep; 25(3):147-51. PubMed ID: 27566015 [TBL] [Abstract][Full Text] [Related]
17. Transcriptional E2F1/2/5/8 as potential targets and transcriptional E2F3/6/7 as new biomarkers for the prognosis of human lung carcinoma. Sun CC; Zhou Q; Hu W; Li SJ; Zhang F; Chen ZL; Li G; Bi ZY; Bi YY; Gong FY; Bo T; Yuan ZP; Hu WD; Zhan BT; Zhang Q; Tang QZ; Li DJ Aging (Albany NY); 2018 May; 10(5):973-987. PubMed ID: 29754146 [TBL] [Abstract][Full Text] [Related]
18. ASCL1-coexpression profiling but not single gene expression profiling defines lung adenocarcinomas of neuroendocrine nature with poor prognosis. Fujiwara T; Hiramatsu M; Isagawa T; Ninomiya H; Inamura K; Ishikawa S; Ushijima M; Matsuura M; Jones MH; Shimane M; Nomura H; Ishikawa Y; Aburatani H Lung Cancer; 2012 Jan; 75(1):119-25. PubMed ID: 21737174 [TBL] [Abstract][Full Text] [Related]
19. Expression and roles of lumican in lung adenocarcinoma and squamous cell carcinoma. Matsuda Y; Yamamoto T; Kudo M; Kawahara K; Kawamoto M; Nakajima Y; Koizumi K; Nakazawa N; Ishiwata T; Naito Z Int J Oncol; 2008 Dec; 33(6):1177-85. PubMed ID: 19020750 [TBL] [Abstract][Full Text] [Related]
20. [Expression of KIF23 and Its Prognostic Role in Non-small Cell Lung Cancer: Analysis Based on the Data-mining of Oncomine]. Ye L; Li H; Zhang F; Lv T; Liu H; Song Y Zhongguo Fei Ai Za Zhi; 2017 Dec; 20(12):822-826. PubMed ID: 29277180 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]